Cargando…

Prognosis of liver abscess with no identified organism

BACKGROUND: There are limited studies focusing on liver abscess with negative microbiological cultures. This study evaluated the clinical and prognostic differences of patients with culture-negative liver abscess (CNLA) compared to those with a positive culture (CPLA) and compared these factors betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jai Hoon, Kim, Youn Jeong, Kim, Sang Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544913/
https://www.ncbi.nlm.nih.gov/pubmed/31151426
http://dx.doi.org/10.1186/s12879-019-4131-z
_version_ 1783423310375157760
author Yoon, Jai Hoon
Kim, Youn Jeong
Kim, Sang Il
author_facet Yoon, Jai Hoon
Kim, Youn Jeong
Kim, Sang Il
author_sort Yoon, Jai Hoon
collection PubMed
description BACKGROUND: There are limited studies focusing on liver abscess with negative microbiological cultures. This study evaluated the clinical and prognostic differences of patients with culture-negative liver abscess (CNLA) compared to those with a positive culture (CPLA) and compared these factors between K. pneumoniae liver abscess (KLA) and E. coli liver abscess (ELA). METHODS: A retrospective study of the patients who admitted with a liver abscess at two tertiary hospitals in Korea from 2012 to 2016 was performed. RESULTS: Among a total of 402 patients with liver abscess, 61.2% had positive cultures. K. pneumoniae (n = 133) was the most common cause, followed by E. coli (n = 74). Patients with CPLA were significantly older (p = 0.02) and more frequently had cholelithiasis or biliary tract disease (p = 0.001) compared to patients with CNLA. In-hospital mortality (p = 0.63) and recurrence (p = 0.77) were no different between the two groups. The length of hospital stay was significantly longer in patients with CPLA (p = 0.03) compared with those with CNLA. Subgroup analysis for patients who received 3rd generation cephalosporins empirically showed that in-hospital mortality (p = 0.18) and recurrence (p = 0.27) were not also significantly different. Cholelithiasis, or biliary tract disease (p = 0.001), liver disease (p = 0.001), malignancy (p = 0.0001), and ESBL production (p = 0.0001) were found more frequently in patients with ELA compared with those with KLA. CONCLUSIONS: The prognosis of the CNLA patients was similar to that of the CPLA patients, although the length of hospital stay was shorter in the CNLA patients. The epidemiologic and clinical characteristics of the ELA patients are somewhat different than those of the KLA patients.
format Online
Article
Text
id pubmed-6544913
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65449132019-06-04 Prognosis of liver abscess with no identified organism Yoon, Jai Hoon Kim, Youn Jeong Kim, Sang Il BMC Infect Dis Research Article BACKGROUND: There are limited studies focusing on liver abscess with negative microbiological cultures. This study evaluated the clinical and prognostic differences of patients with culture-negative liver abscess (CNLA) compared to those with a positive culture (CPLA) and compared these factors between K. pneumoniae liver abscess (KLA) and E. coli liver abscess (ELA). METHODS: A retrospective study of the patients who admitted with a liver abscess at two tertiary hospitals in Korea from 2012 to 2016 was performed. RESULTS: Among a total of 402 patients with liver abscess, 61.2% had positive cultures. K. pneumoniae (n = 133) was the most common cause, followed by E. coli (n = 74). Patients with CPLA were significantly older (p = 0.02) and more frequently had cholelithiasis or biliary tract disease (p = 0.001) compared to patients with CNLA. In-hospital mortality (p = 0.63) and recurrence (p = 0.77) were no different between the two groups. The length of hospital stay was significantly longer in patients with CPLA (p = 0.03) compared with those with CNLA. Subgroup analysis for patients who received 3rd generation cephalosporins empirically showed that in-hospital mortality (p = 0.18) and recurrence (p = 0.27) were not also significantly different. Cholelithiasis, or biliary tract disease (p = 0.001), liver disease (p = 0.001), malignancy (p = 0.0001), and ESBL production (p = 0.0001) were found more frequently in patients with ELA compared with those with KLA. CONCLUSIONS: The prognosis of the CNLA patients was similar to that of the CPLA patients, although the length of hospital stay was shorter in the CNLA patients. The epidemiologic and clinical characteristics of the ELA patients are somewhat different than those of the KLA patients. BioMed Central 2019-05-31 /pmc/articles/PMC6544913/ /pubmed/31151426 http://dx.doi.org/10.1186/s12879-019-4131-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yoon, Jai Hoon
Kim, Youn Jeong
Kim, Sang Il
Prognosis of liver abscess with no identified organism
title Prognosis of liver abscess with no identified organism
title_full Prognosis of liver abscess with no identified organism
title_fullStr Prognosis of liver abscess with no identified organism
title_full_unstemmed Prognosis of liver abscess with no identified organism
title_short Prognosis of liver abscess with no identified organism
title_sort prognosis of liver abscess with no identified organism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544913/
https://www.ncbi.nlm.nih.gov/pubmed/31151426
http://dx.doi.org/10.1186/s12879-019-4131-z
work_keys_str_mv AT yoonjaihoon prognosisofliverabscesswithnoidentifiedorganism
AT kimyounjeong prognosisofliverabscesswithnoidentifiedorganism
AT kimsangil prognosisofliverabscesswithnoidentifiedorganism